GenVec Technology Used to Restore Lost Balance Function
GAITHERSBURG, Md., April 11, 2011 /PRNewswire via COMTEX/ -- GenVec, Inc. (GNVC)
announced that new research has been published online ahead of print in the
journal Gene Therapy, and can be accessed at
nature.com.
The article, "Selective atonal gene delivery improves balance function in a mouse
model of vestibular disease," describes research conducted by Hinrich Staecker,
M.D., Ph.D. and colleagues at the University of Kansas School of Medicine, in
which the use of a vector targeted to and limited in expression to supporting
cells can be used to restore balance function in an animal model.
"This research contributes to our understanding of how GenVec's technology can be
applied in the field of regenerative medicine," noted Douglas E. Brough, Ph.D.,
GenVec's Vice President of Research. "Our proprietary technology can stimulate
gene expression in target cells and lead to improved function. These next
generation vectors provide the additional advantage of more selective gene
delivery." |
